Granite Bio (Series A and Series B)

Funding Details
Awarder
Inbox
Date Award
April 29, 2025
Vertical
Biotechnology
Funding URL
View Funding Page

Company Info
Founders
Patrick Loustau, Dominik Hartl, Gijs van den Brink, Eliot Forster
Company Description
Granite Bio is a biotechnology business developing novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.
Market
Immunology
Location
Basel, Switzerland
Coinvestors
Versant Ventures, Novartis Venture Fund, Forbion, Sanofi Ventures

Links
Back to Home Back to Biotechnology Deals View Funding Announcement